Cargando…

Is insulin-like growth factor-1 involved in Parkinson’s disease development?

Parkinson’s disease (PD) is a neurodegenerative disorder that results in the death of dopaminergic neurons within the substantia nigra pars compacta and the reduction in dopaminergic control over striatal output neurons, leading to a movement disorder most commonly characterized by akinesia or brady...

Descripción completa

Detalles Bibliográficos
Autores principales:	Castilla-Cortázar, Inma, Aguirre, Gabriel A., Femat-Roldán, Giovana, Martín-Estal, Irene, Espinosa, Luis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7014772/ https://www.ncbi.nlm.nih.gov/pubmed/32046737 http://dx.doi.org/10.1186/s12967-020-02223-0

Ejemplares similares

Mexican case report of a never‐treated Laron syndrome patient evolving to metabolic syndrome, type 2 diabetes, and stroke
por: Castilla‐Cortazar, Inma, et al.
Publicado: (2017)

Altered Body Composition and Increased Resting Metabolic Rate Associated with the Postural Instability/Gait Difficulty Parkinson's Disease Subtype
por: Femat-Roldán, Giovana, et al.
Publicado: (2020)

Insulin-Like Growth Factor-1 Deficiency and Cirrhosis Establishment
por: de la Garza, Rocio G., et al.
Publicado: (2017)

Human conditions of insulin-like growth factor-I (IGF-I) deficiency
por: Puche, Juan E, et al.
Publicado: (2012)

Primary growth hormone insensitivity and psychomotor delay
por: Castilla‐Cortazar, Inma, et al.
Publicado: (2018)

Liver mitochondrial dysfunction is reverted by insulin-like growth factor II (IGF-II) in aging rats
por: Garcia-Fernandez, Maria, et al.
Publicado: (2011)

Clinical and molecular diagnosis of a cartilage‐hair hypoplasia with IGF‐1 deficiency
por: Castilla‐Cortázar, Inma, et al.
Publicado: (2016)

Partial IGF-1 deficiency is sufficient to reduce heart contractibility, angiotensin II sensibility, and alter gene expression of structural and functional cardiac proteins
por: González-Guerra, José Luis, et al.
Publicado: (2017)

Insulin-like growth factor-1 deficiency and metabolic syndrome
por: Aguirre, G. A., et al.
Publicado: (2016)

Antioxidant effects of insulin-like growth factor-I (IGF-I) in rats with advanced liver cirrhosis
por: García-Fernández, María, et al.
Publicado: (2005)

Little effects of Insulin-like Growth Factor-I on testicular atrophy induced by hypoxia
por: Diez-Caballero, Fernando, et al.
Publicado: (2006)

Growth hormone insensitivity: Mexican case report
por: Castilla-Cortazar, I, et al.
Publicado: (2017)

IGF-1 modulates gene expression of proteins involved in inflammation, cytoskeleton, and liver architecture
por: Lara-Diaz, VJ, et al.
Publicado: (2017)

Jejunal microvilli atrophy and reduced nutrient transport in rats with advanced liver cirrhosis: improvement by Insulin-like Growth Factor I
por: Castilla-Cortázar, Inma, et al.
Publicado: (2004)

Gestational Diabetes Mellitus and Energy-Dense Diet: What Is the Role of the Insulin/IGF Axis?
por: Martín-Estal, Irene, et al.
Publicado: (2022)

Effect of Ethanol Consumption on the Placenta and Liver of Partially IGF-1-Deficient Mice: The Role of Metabolism via CYP2E1 and the Antioxidant Enzyme System
por: Martín-Estal, Irene, et al.
Publicado: (2022)

Experimental approach to IGF-1 therapy in CCl(4)-induced acute liver damage in healthy controls and mice with partial IGF-1 deficiency
por: Morales-Garza, Luis A., et al.
Publicado: (2017)

Altered liver expression of genes involved in lipid and glucose metabolism in mice with partial IGF-1 deficiency: an experimental approach to metabolic syndrome
por: De Ita, J. Rodríguez, et al.
Publicado: (2015)

Athetoid Movements as Initial Manifestation of Primary Sjögren Syndrome
por: Alvarado‐Franco, Norma L., et al.
Publicado: (2018)

Hepatoprotection and neuroprotection induced by low doses of IGF-II in aging rats
por: Castilla-Cortázar, Inma, et al.
Publicado: (2011)

Insulin-like growth factor II prevents oxidative and neuronal damage in cellular and mice models of Parkinson's disease
por: Martín-Montañez, Elisa, et al.
Publicado: (2021)

Serum Insulin-Like Growth Factor-1 and Nitric Oxide Levels in Parkinson's Disease
por: Tuncel, Deniz, et al.
Publicado: (2009)

Insulin-Like Growth Factors in Development, Cancers and Aging
por: Werner, Haim
Publicado: (2020)

A 42-Year-Old Woman with Untreated Growth Hormone Insensitivity, Diabetic Retinopathy, and Gene Sequencing Identifies a Variant of Laron Syndrome
por: Castilla-Cortazar, Inma, et al.
Publicado: (2019)

An Insulin-Like Growth Factor in Rhodnius prolixus Is Involved in Post-feeding Nutrient Balance and Growth
por: Defferrari, Marina S., et al.
Publicado: (2016)

Role of Insulin-like Growth Factor, Insulin-like Growth Factor Receptors, and Insulin-like Growth Factor-binding Proteins in Ovarian Cancer
por: Amutha, Periyasamy, et al.
Publicado: (2017)

Insulin-like growth factors in embryonic and fetal growth and skeletal development (Review)
por: AGROGIANNIS, GEORGIOS D., et al.
Publicado: (2014)

Glypican-3-mediated oncogenesis involves the Insulin-like growth factor-signaling pathway
por: Cheng, Wei, et al.
Publicado: (2008)

A Twenty-First Century Cancer Epidemic Caused by Obesity: The Involvement of Insulin, Diabetes, and Insulin-Like Growth Factors
por: Westley, Rosalyne L., et al.
Publicado: (2013)

Nitric Oxide Involvement in Cardiovascular Dysfunctions of Parkinson Disease
por: Martins-Pinge, Marli Cardoso, et al.
Publicado: (2022)

Insulin-like growth factors and insulin-like growth factor binding proteins in mammary gland function
por: Marshman, Emma, et al.
Publicado: (2002)

The Role of Insulin-Like Growth Factors and Insulin-Like Growth Factor–Binding Proteins in the Nervous System
por: Lewitt, Moira S, et al.
Publicado: (2019)

Insulin-like growth factor regulation of mammary gland development and tumorigenesis
por: Lee, AV
Publicado: (2005)

The emerging role of insulin-like growth factors in testis development and function
por: Griffeth, Richard J, et al.
Publicado: (2014)

Insulin-Like Growth Factor 1: At the Crossroads of Brain Development and Aging
por: Wrigley, Sarah, et al.
Publicado: (2017)

The Insulin-like Growth Factor Signalling Pathway in Cardiac Development and Regeneration
por: Díaz del Moral, Sandra, et al.
Publicado: (2021)

Building the Case for Insulin-Like Growth Factor Receptor-I Involvement in Thyroid-Associated Ophthalmopathy
por: Smith, Terry J., et al.
Publicado: (2017)

Insulin-like growth factor 2 and autophagy gene expression alteration arise as potential biomarkers in Parkinson’s disease
por: Sepúlveda, Denisse, et al.
Publicado: (2022)

The Insulin-Like Growth Factor System
por: Roith, Derek Le
Publicado: (2003)

Insulin-like growth factors and cancer.
por: Macaulay, V. M.
Publicado: (1992)

Cannot write session to /tmp/vufind_sessions/sess_k4e1g6a5o6t9l82a6l22d9iu8p